• Adjarov D, Popov S, Ivanov E. Studies on the mechanism of the changes in serum and liver gamma-glutamyl transpeptidase activity. I. Experimental extrahepatic cholestasis in rabbits. Enzyme 21: 1-7 (1976).

• Arima T, Motoyama Y, Nagata K, Kondo T. Serum glycoproteins in the liver diseases. II. Radioimmunoassay of alpha-1 acid glycoprotein. Gastroenterol. Jpn. 11: 307-312 (1976).

• Arnett FC, Shulman LE. Studies in familial systemic lupus erythematosus. Medicine (Baltimore) 55: 313-322 (1976).

• Ball GV, Goldman LN. Chronic ulcerative colitis, skin necrosis, and cryofibrinogenemia. Ann. Intern. Med. 85: 464-466 (1976).

• Banwell JG. Obstruction of the bile ducts. J. Ky. Med. Assoc. 74: 292-296 (1976).

• Bauer JJ, Gelernt IM, Kreel I. Portosystemic shunting in patients with primary biliary cirrhosis: a good risk disease. Ann. Surg. 183: 324-328 (1976). *

• Beattie AD, Sherlock S. Ascorbic acid deficiency in liver disease. Gut 17: 571-575 (1976). *

• Beppu M, Horikawa S, Hikita K, Kurita K, Hirai T. Primary sclerosing cholangitis - a case report. Nippon Shokakibyo Gakkai Zasshi 73: 1590-1598 (1976).

• Bergman L, Lindblom JB, Safwenberg J, Krause U. HL-A frequencies in Crohn's disease and ulcerative colitis. Tissue Antigens 7: 145-150 (1976).

• Bloomer JR, Allen RM, Klatskin G. Serum bile acids in primary biliary cirrhosis. Arch. Intern. Med. 136: 57-61 (1976).

• Bootello A, Fernandez-Cruz E, Escartin P, Blanco MF, Gosalvez M, Segovia De Arana JM. Injurious effect on rat liver mitochondria by lymphocytes from patients with primary biliary cirrhosis. Clin. Exp. Immunol. 24: 374-377 (1976). *

• Bremmelgaard A, Pedersen L. Bile acids in bile during long-term chenodeoxycholic acid treatment. Scand. J. Gastroenterol. 11: 161-165 (1976).

• Cave DR, Mitchell DN, Brooke BN. Evidence of an agent transmissible from ulcerative colitis tissue. Lancet 1: 1311-1315 (1976).

• Cederblad G, Korsan-Bengtsen K, Olsson R. Observations of increased levels of blood coagulation factors and other plasma proteins in cholestatic liver disease. Scand. J. Gastroenterol. 11: 391-396 (1976).

• Cochrane AM, Tsantoulos DC, Moussouros A, McFarlane IG, Eddleston AL, Williams R. Lymphocyte cytotoxicity for kidney cells in renal tubular acidosis of autoimmune liver disease. Br. Med. J. 2: 276-278 (1976). *

• Collier HO, Francis AA, McDonald-Gibson WJ, Saeed SA. Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites. Prostaglandins 11: 219-225 (1976).

• Czaja AJ, McAlhany JC, Pruitt BA Jr. Gastric acid secretion and acute gastroduodenal disease after burns. Arch. Surg. 111: 243-245 (1976).

• Dacremont G, Hildebrand J. Characterization of two gangliosides from human leukemic polymorphonuclear leukocytes. Biochim. Biophys. Acta 424: 315-322 (1976).

• Danzi JT, Makipour H, Farmer RG. Primary sclerosing cholangitis. A report of nine cases and clinical review. Am. J. Gastroenterol. 65: 109-116 (1976).

• Das KM, Dubin R. Clinical pharmacokinetics of sulphasalazine. Clin. Pharmacokinet. 1: 406-425 (1976).

• de Pagter AG, van Berge Henegouwen GP, ten Bokkel Huinink JA, Brandt KH. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives? Gastroenterology 71: 202-207 (1976).

• Elias E. Cholangiography in the jaundiced patient. Gut 17: 801-811 (1976). *

• Ellestad-Sayed JJ, Nelson RA, Adson MA, Palmer WM, Soule EH. Pantothenic acid, coenzyme A, and human chronic ulcerative and granulomatous colitis. Am. J. Clin. Nutr. 29: 1333-1338 (1976). *

• Espiritu CR, Alalu J, Glueckauf LG, Lubin J. Allopurinol-induced granulomatous hepatitis. Am. J. Dig. Dis. 21: 804-806 (1976).

• Euler AR, Ament ME. Crohn's disease - a cause of arthritis, oxalate stones and fistulae in cystic fibrosis. West. J. Med. 125: 315-317 (1976).

• Fausa O. Serum bile acid concentration after a test meal. Scand. J. Gastroenterol. 11: 229-232 (1976).

• Ferenci P, Dragosics B, Pesendorfer FX, Schubert H. Gamma-glutamyl-transpeptidase in alcoholic liver diseases. Acta Med. Austriaca 3: 50-54 (1976).

• Fernandez-Cruz E, Bootello A, Blanco MF, Gosalvez M, Segovia de Arana JM. Primary biliary cirrhosis. Study of the action of mitochondrial antibody plus complement on mitochondrial membrane functions. Allergol. Immunopathol. (Madr.) 4: 145-152 (1976).

• Galant SP. Immunobiology of the gastrointestinal tract. Compr. Ther. 2: 35-39 (1976).

• Ganc AJ, Reibscheid S, Nusbaum L, Feiman R, Maranhao RF, Vilela MP. The intra-hepatic biliary system in cirrhosis. G. E. N. 31: 123-130 (1976).

• Garnica AD. The hepatotoxicity of parenteral protein hydrolysate-containing solutions. Ann. Clin. Lab. Sci. 6: 446-454 (1976).

• Gay S, Muller PK, Meigel WN, Kuhn K. The polymorphism of collagen. New viewpoints on the structure and function of connective tissue. Hautarzt. 27: 196-205 (1976).

• Gerber NL, Steinberg AD. Clinical use of immunosuppressive drugs: part II. Drugs 11: 90-112 (1976).

• Geubel AP, Baggenstoss AH, Summerskill WH. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology 71: 444-449 (1976).

• Geubel AP, Keller RH, Summerskill WH, Dickson ER, Tomasi TB, Shorter RG. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. Gastroenterology 71: 450-456 (1976).

• Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55: 401-412 (1976).

• Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase I. Demonstration of activity in normal serum, and an increase in cholestatic liver disease. Scand. J. Gastroenterol. 11: 121-127 (1976).

• Heathcote J, Deodhar KP, Scheuer PJ, Sherlock S. Intrahepatic cholestasis in childhood. N. Engl. J. Med. 295: 801-805 (1976).

• Heathcote J, Ross A, Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 70: 656-660 (1976).

• Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am. J. Med. Sci. 272: 285-299 (1976).

• Hood L. Antibody genes and other multigene families. Fed. Proc. 35: 2158-2167 (1976).

• Hyla JF, Franck WA, Davis JS. Lack of association of HLA B27 with radiographic sacroiliitis in inflammatory bowel disease. J. Rheumatol. 3: 196-200 (1976).

• Isaacson P. Tissue demonstration of carcinoembryonic antigen (CEA) in ulcerative colitis. Gut 17: 561-567 (1976). *

• Isenberg JN, L'Heureux PR, Warwick WJ, Sharp HL. Clinical observations on the biliary system in cystic fibrosis. Am. J. Gastroenterol. 65: 134-141 (1976).

• Jain S, Markham R, Thomas HC, Sherlock S. Double-stranded DNA-binding capacity of serum in acute and chronic liver disease. Clin. Exp. Immunol. 26: 35-41 (1976). *

• Kampa IS, Jarzabek J, Clain J. The use of gamma-glutamyl transpeptidase in differentiating liver from bone isoenzymes of alkaline phosphatase. Clin. Biochem. 9: 234-236 (1976).

• Keighley MR, Drysdale RB, Quoraishi AH, Burdon DW, Alexander-Willians J. Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum. Gut 17: 495-500 (1976). *

• Kobayashi A, Utsunomiya T, Kawai S, Ohbe Y. Congenital biliary atresia. Analysis of 97 cases with reference to prognosis after hepatic portoenterostomy. Am. J. Dis. Child. 130: 830-833 (1976).

• Konig H, Hermanek P, Rosch W. Clinical conference: unusual course of chronic colitis. Acta Hepatogastroenterol. (Stuttg.) 23: 227-231 (1976).

• Kratzsch KH, Zimmermann S, Morenz J, Furstenau M, Zugehor M, Claus B, Lewicki I. Humoral immune reaction in chronic liver diseases. Z. Gesamte. Inn. Med. 31: 533-545 (1976).

• Kueppers F, Dickson ER, Summerskill WH. Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis. Mayo Clin. Proc. 51: 286-288 (1976).

• Kutzner M, Sziegoleit W. Adverse effects of allopurinol. Z. Arztl. Fortbild. (Jena) 70: 1017-1020 (1976).

• Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann. Rheum. Dis. 35: 354-356 (1976). *

• Lebrec D, Sicot C, Degott C, Benhamou JP. Portal hypertension and primary biliary cirrhosis. Digestion 14: 220-226 (1976).

• Lederberg S, Sackett D. Distribution of complement C3 variants in individuals with cystic fibrosis. Am. J. Hum. Genet. 28: 597-601 (1976). *

• Lewkonia RM, McConnell RB. Progress report. Familial inflammatory bowel disease - heredity or environment? Gut 17: 235-243 (1976). *

• Lockard O Jr, Harmon C, Nolph K, Irvin W. Allergic reaction to allopurinol with cross-reactivity to oxypurinol. Ann. Intern. Med. 85: 333-335 (1976).

• Long RG, Skinner RK, Wills MR, Sherlock S. Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet 2: 650-652 (1976).

• Macak J. Antibodies against mitochondria and smooth muscle in primary biliary cirrhosis. Cesk. Patol. 12: 175-179 (1976).

• MacPherson BR, Albertini RJ, Beeken WL. Immunological studies in patients with Crohn's disease. Gut 17: 100-106 (1976). *

• Magnani HN, Alaupovic P. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases. Gastroenterology 71: 87-93 (1976).

• Maleev A, Matincheva R, Ognianov M, Vradzhaliev N. Immunological studies of patients with chronic ulcerative-hemorrhagic colitis. Vutr. Boles. 15: 32-36 (1976).

• Mallas EG, Mackintosh P, Asquith P, Cooke WT. Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27). Gut 17: 906-910 (1976). *

• McAlhany JC Jr, Colmic L, Czaja AJ, Pruitt BA Jr. Antacid control of complications from acute gastroduodenal disease after burns. J. Trauma 16: 645-648 (1976).

• McFarlane IG, Wojcicka BM, Tsantoulas DC, Funk C, Portmann B, Eddleston AL, Williams R. Cellular immune responses to salivary antigens in autoimmune liver disease with sicca syndrome. Clin. Exp. Immunol. 25: 389-395 (1976). *

• McMenamin RA, Davies LM, Craswell PW. Drug induced interstitial nephritis, hepatitis and exfoliative dermatitis. Aust. N. Z. J. Med. 6: 583-587 (1976).

• Meijer S, Hoitsma HF, Scholtmeijer R. Idiopathic retroperitoneal fibrosis in multifocal fibrosclerosis. Eur. Urol. 2: 258-260 (1976).

• Meuwissen SG, Feltkamp-Vroom TM, De La Riviere AB, Von Dem Borne AE, Tytgat GN. Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations. Gut 17: 770-780 (1976). *

• Meyer S, Hausman R. Occlusive phlebitis in multifocal fibrosclerosis. Am. J. Clin. Pathol. 65: 274-283 (1976).

• Misra AL, Bloch R, Vardy J, Mule SJ, Verebely K. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat. Drug Metab. Dispos. 4: 276-280 (1976).

• Mitchell DN, Rees RJ, Goswami KK. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet 2: 761-765 (1976).

• Mullens JE, Laufer I. Endoscopic retrograde cholangiopancreatography in the management of pancreatic and biliary disease. Can. J. Surg. 19: 405-409 (1976).

• Negut EA. Role of the liver in detoxification of endotoxins. Rev. Ig Bacteriol. Virusol. Parazitol. Epidemiol. Pneumoftiziol. Bacteriol. Virusol. Parazitol. Epidemiol. 21: 1-10 (1976).

• Newby TJ, Bourne FJ. The nature of the local immune system of the bovine small intestine. Immunology 31: 475-480 (1976). *

• No authors listed. An unusual cholangitis. Br. Med. J. 2: 1090-1091 (1976). *

• Norgaard-Pedersen B, Axelsen NH. Alpha-fetoprotein-like activity in sera from patients with malignant and non-malignant disease and healthy individuals. Clin. Chim. Acta 71: 343-347 (1976).

• Ohlen J, Richter J. Distribution pattern of isoenzymes of alkaline phosphatase in patients with various forms of hepatitis. Med. Klin. 71: 292-299 (1976).

• PetitClerc C. Quantitative fractionation of alkaline phosphatase isoenzymes according to their thermostability. Clin. Chem. 22: 42-48 (1976).

• Potter BJ, Elias E, Jones EA. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J. Lab. Clin. Med. 88: 427-439 (1976).

• Read G, Braganza JM, Howat HT. Pancreatitis - a retrospective study. Gut 17: 945-952 (1976). *

• Reuter SR, Chuang VP. The location of increased resistance to portal blood flow in obstructive jaundice. Invest. Radiol. 11: 54-59 (1976).

• Roberts ME, Wright V, Hill AG, Mehra AC. Psoriatic arthritis. Follow-up study. Ann. Rheum. Dis. 35: 206-212 (1976). *

• Roerig S, Fujimoto JM, Wang RI, Pollock SH, Lange D. Preliminary characterization of enzymes for reduction of naloxone and naltrexone in rabbit and chicken liver. Drug Metab. Dispos. 4: 53-58 (1976).

• Ruskin RB, Katon RM, Bilbao MK, Smith F. Evaluation of sclerosing cholangitis by endoscopic retrograde cholangiopancreatography. Arch. Intern. Med. 136: 232-235 (1976).

• Salaspuro M, Sipponen P. Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases. Gut 17: 787-790 (1976). *

• Salaspuro MP, Laitinen OI, Lehtola J, Makkonen H, Rasanen JA, Sipponen P. Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosis. Scand. J. Gastroenterol. 11: 313-320 (1976).

• Salaspuro MP, Sipponen P, Ikkala E, Kolho L, Makkonen HM, Miettinen TA, Rasanen JA, Siurala M. Clinical correlations and significance of orceinpositivity in chronic active hepatitis and primary biliary cirrhosis. Ann. Clin. Res. 8: 206-215 (1976).

• Salaspuro MP, Sipponen P, Makkonen H. The occurrence of orcein-positive hepatocellular material in various liver diseases. Scand. J. Gastroenterol. 11: 677-681 (1976).

• Salerno F, Fargion SR, Cappellini MD, Fiorelli G, Dioguardi N. Rosette inhibition test in chronic liver disease. J. Clin. Pathol. 29: 778-781 (1976). *

• Samsioe G, Lundborg H, Ivarsson S, Gustafson A. On the occurrence of lipoprotein-X in non-hemolytic jaundice. Acta Chir. Scand. 142: 187-190 (1976).

• Schmidt G, Kienle J, Schmidt DS, Brunner G. Frequency of chronic non-suppurative destructive cholangitis and primary biliary cirrhosis in comparison with other chronic inflammatory liver diseases. Dtsch. Med. Wochenschr. 101: 693-696 (1976).

• Scott BB, Losowsky MS. Depressed cell-mediated immunity in coeliac disease. Gut 17: 900-905 (1976). *

• Shakib F, Stanworth DR, Smalley CA, Brown GA. Elevated serum IgG4 levels in cystic fibrosis patients. Clin. Allergy 6: 237-240 (1976).

• Sharma RV, Mathur SN, Ganguly J. Studies on the relative biopotencies and intestinal absorption of different apo-beta-carotenoids in rats and chickens. Biochem. J. 158: 377-383 (1976).

• Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 17: 332-334 (1976). *

• Sipponen P. Orcein positive hepatocellular material in long-standing biliary diseases. II. Ultrastructural studies. Scand. J. Gastroenterol. 11: 553-557 (1976).

• Sipponen P. Orcein positive hepatocellular material in long-standing biliary diseases. I. Histochemical characteristics. Scand. J. Gastroenterol. 11: 545-552 (1976).

• Sipponen P, Salaspuro MP, Makkonen H. Histological characteristics of chronic hepatides and primary biliary cirrhosis with special reference to orcein positive hepatocellular accumulations. Ann. Clin. Res. 8: 200-205 (1976).

• Smith FR, Henkin RI, Dell RB. Disordered gustatory acuity in liver disease. Gastroenterology 70: 568-571 (1976).

• Snape WJ Jr, Long WB, Trotman BW, Marin GA, Czaja AJ. Marked alkaline phosphatase elevation with partial common bile duct obstruction due to calcific pancreatitis. Gastroenterology 70: 70-73 (1976).

• Strober W, Krakauer R, Klaeveman HL, Reynolds HY, Nelson DL. Secretory component deficiency. A disorder of the IgA immune system. N. Engl. J. Med. 294: 351-356 (1976).

• Summerfield JA, Elias E, Hungerford GD, Nikapota VL, Dick R, Sherlock S. The biliary system in primary biliary cirrhosis. A study by endoscopic retrograde cholangiopancreatography. Gastroenterology 70: 240-243 (1976).

• Thomas HC, Freni M, Sanchez-Tapias J, de Villiers D, Jain S, Sherlock S. Peripheral blood lymphocyte populations in chronic liver disease. Clin. Exp. Immunol. 26: 222-227 (1976). *

• Thomas HC, Holden R, Jones JV, Peacock DB. Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis. Gut 17: 844-848 (1976). *

• Tong MJ, Nies KM, Reynolds TB, Quismorio FP. Immunological studies in familial primary biliary cirrhosis. Gastroenterology 71: 305-307 (1976).

• Triger DR, Gamlen TR, Paraskevas E, Lloyd RS, Wright R. Measles antibodies and autoantibodies in autoimmune disorders. Clin. Exp. Immunol. 24: 407-414 (1976). *

• Utsinger PD, Young WJ. Allopurinol hypersensitivity. Granular deposition of IgM at the dermal-epidermal junction. Am. J. Med. 61: 287-294 (1976).

• van Berge Henegouwen GP, Brandt KH, Eyssen H, Parmentier G. Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis. Gut 17: 861-869 (1976). *

• Viteri A, Vernace SJ, Schaffner F. Extrahepatic malignancy in chronic liver disease: report of six cases. Gastroenterology 71: 1075-1078 (1976).

• Wagonfeld JB, Nemchausky BA, Bolt M, Horst JV, Boyer JL, Rosenberg IH. Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis. Lancet 2: 391-394 (1976).

• Warshaw AL, Schapiro RH, Ferrucci JT Jr, Galdabini JJ. Persistent obstructive jaundice, cholangitis, and biliary cirrhosis due to common bile duct stenosis in chronic pancreatitis. Gastroenterology 70: 562-567 (1976).

• Weber AM, Roy CC, Chartrand L, Lepage G, Dufour OL, Morin CL, Lasalle R. Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis. Gut 17: 295-299 (1976). *

• Williams CN. Bile-acid metabolism and the liver. Clin. Biochem. 9: 149-152 (1976).

• Winkel P, Juhl E, Tygstrup N. The clinical significance of classifications of cirrhosis. A comparison between conventional criteria and numerical taxonomy. Scand. J. Gastroenterol. 11: 33-40 (1976).

• Yanaura S, Ishikawa S. Effect of ursodeoxycholic acid on bile secretion and bile components. Comparison with chenodeoxycholic acid and dehydrocholic acid. Nippon Yakurigaku Zasshi 72: 689-700 (1976).

Number of references = 115

www psc-literature.org